Search results for LOXL2 antibody

LOXL2 Antibody (YA1606), MedChemexpress, HY-P81861

LOXL2 Antibody (YA1606) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to LOXL2.

LOXL2 antibody [HL4109], Genetex, GTX642555

LOXL2 antibody [HL4379], Genetex, GTX643636

Anti-LOXL2 Antibody (R2L56), AntibodySystem, RHK06602

Anti-LOXL2 Antibody (R2L57), AntibodySystem, RHK06603

Anti-LOXL2 antibody [2E5], Abcam, AB302884

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-LOXL2 antibody [7HCLC], Abcam, AB277807

What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies .

Anti-Human LOXL2 Antibody (SAA2215), AntibodySystem, RHK06601

Anti-LOXL2 antibody [EPR23035-105], Abcam, AB260046

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-LOXL2 antibody [EPR28298-7], Abcam, AB314140

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .